1

IQVIA

An American multinational company serving the combined industries of health information technology and clinical research.

Categories

Pharma and Life Sciences  
Technology  

#563

Rank

$35.8B

Marketcap

US United States

Country

IQVIA
Leadership team

Carol J. Burt (Board Member)

Eric M. Sherbet (EVP & General Counsel)

Industries

Pharma and Life Sciences

Technology

Products/ Services
Support services for pharmaceutical, biotech and medical companies and individuals
Number of Employees
20,000 - 50,000
Headquarters
Danbury, Connecticut, United States
Established
1982
Company Type
Public Limited Company
Company Registration
SEC CIK number: 0001478242
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
IQV
Social Media
Overview
Location
Summary

IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.

History

1985: By 1985, Quintiles, Inc. had arranged to provide contract services worth millions of dollars to a number of large pharmaceutical firms in the United States.

1987: In January 1987, Quintiles Ltd. began operations to serve clients in the United Kingdom.

1988: In 1988, the company opened an office in Cambridge, Massachusetts to provide contract services to pharmaceutical and biotechnology firms located in the northeastern section of the United States.

1990: In August 1990, Quintiles Pacific, Inc. was established to provide contract services for the biotechnological and pharmaceutical firms in the western United States and around the Pacific Rim.

1991: In 1991, Quintiles GmbH was established in Germany to augment the company's contract services to European clients, and Quintiles Laboratories, Ltd. was created in Atlanta, Georgia to provide contract clinical trial laboratory services to companies that were developing healthcare products.

1996: Continuing its frenetic pace of growth and expansion, in 1996 the company opened offices in Pretoria, South Africa, Vienna, Austria, Helsinki, Finland, Madrid, Spain, and Buenos Aires, Argentina.

1997: Quintiles announced in February 1997 that it had become a publicly traded company.

1999: 1999: Company joins the S&P 500 Index.

2000: Quintiles realigned its operating units, early in 2000, due to recent changes in the development of drugs and the introduction of new medicines; and their impacts to the healthcare industry.

2002: In early 2002, Quintiles bought certain assets of Bioglan Pharma Inc., the United States subsidiary of U.K.-based Bioglan Pharma Plc.

2004: In the first six months of 2004, Quintiles saw an increase of almost a billion dollars in new business.

2015: The acquisition has helped IQVIA grow after-tax operating profit (NOPAT) by 39%, from $495 million in 2015 to $687 million over the past twelve months.

2018: Revenue grew 9% year over year in Q1 2018, and the company’s R&D backlog increased 57%.

Mission

According to IQVIA, the company mission is: “to help customers and partners do extraordinary things for healthcare". 

Vision

As stated in company website, IQVIA vision is:" to bring together advances in data science, technology, and healthcare expertise to help customers make better decisions and ultimately improve patient outcomes".

Key Team

John G. Danhakl (Board Member)

James A. Fasano (Board Member)

John M. Leonard (Board Member)

John G. Danhakl (Board Member)

John P. Connaughton (Board Member)

John M. Leonard (Board Member)

Jonathan Coslet (Board Member)

John P. Connaughton (Board Member)

Michael Evanisko (Board Member)

Jonathan Coslet (Board Member)

Ronald A. Rittenmeyer (Board Member)

Kevin C. Knightly (President)

Todd B. Sisitsky (Board Member)

Michael Evanisko (Board Member)

Ari Bousbib (CEO)

Carol J. Burt (Board Member)

James A. Fasano (Board Member)

Recognition and Awards
Fortune 500
References
IQVIA
Leadership team

Carol J. Burt (Board Member)

Eric M. Sherbet (EVP & General Counsel)

Industries

Pharma and Life Sciences

Technology

Products/ Services
Support services for pharmaceutical, biotech and medical companies and individuals
Number of Employees
20,000 - 50,000
Headquarters
Danbury, Connecticut, United States
Established
1982
Company Type
Public Limited Company
Company Registration
SEC CIK number: 0001478242
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
IQV
Social Media